瑞金克斯生物公司
DE ˙ DB ˙ US75901B1070
€6.20 ↓ -0.10 (-1.59%)
2026-06-02
分享價格
SecurityDE:RB0 / REGENXBIO Inc.
InstitutionState Street Corp
Latest Disclosed Ownership2,731,553 shares
Ownership 5.30%
State Street Corp ownership in RB0 / REGENXBIO Inc.

2026-05-12 - State Street Corp has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,731,553 shares of REGENXBIO Inc. (DE:RB0). This represents 5.3 percent ownership of the company. In their previous filing dated 2025-02-05 , State Street Corp had reported owning 2,185,851 shares, indicating an increase of 24.97 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-05-12 2026-05-12 13G 2,185,851 2,731,553 24.97 5.30 20.45
2025-02-05 2025-02-05 13G 2,631,220 2,185,851 -16.93 4.40 -26.42
2024-01-25 2024-01-25 13G/A 2,716,189 2,631,220 -3.13 5.98 -4.63
2023-02-03 2023-02-03 13G/A 2,490,253 2,716,189 9.07 6.27 7.73
2022-02-11 2022-02-11 13G/A 1,821,656 2,490,253 36.70 5.82 19.51
2021-02-16 2021-02-16 13G/A 1,877,130 1,821,656 -2.96 4.87 -4.32
2020-02-14 2020-02-14 13G 1,974,759 1,877,130 -4.94 5.09 -7.45
2019-02-13 2019-02-13 13G 1,974,759 5.50

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F REGENXBIO COM 75901B107 2,731,485 444,749 19.45 22,890 -30.49 0.0008
2026-02-13 2025-12-31 13F REGENXBIO COM 75901B107 2,286,736 301,858 15.21 32,929 71.91 0.0011
2025-11-14 2025-09-30 13F REGENXBIO COM 75901B107 1,984,878 141,233 7.66 19,154 26.55 0.0007
2025-08-14 2025-06-30 13F REGENXBIO COM 75901B107 1,843,645 777,552 72.93 15,136 98.58 0.0006
2025-05-15 2025-03-31 13F REGENXBIO COM 75901B107 1,066,093 -1,119,758 -51.23 7,623 -54.89 0.0003
2025-02-14 2024-12-31 13F REGENXBIO COM 75901B107 2,185,851 -597,032 -21.45 16,897 -42.12 0.0007
2024-11-14 2024-09-30 13F REGENXBIO COM 75901B107 2,782,883 -90,352 -3.14 29,192 -13.16 0.0012
2024-08-14 2024-06-30 13F REGENXBIO COM 75901B107 2,873,235 -249,404 -7.99 33,617 -48.91 0.0015
2024-05-15 2024-03-31 13F REGENXBIO COM 75901B107 3,122,639 491,419 18.68 65,794 39.31 0.0029
2024-02-14 2023-12-31 13F REGENXBIO COM 75901B107 2,631,220 127,739 5.10 47,230 14.62 0.0023
2023-11-14 2023-09-30 13F REGENXBIO COM 75901B107 2,503,481 -258,635 -9.36 41,207 -25.37 0.0023
2023-08-14 2023-06-30 13F REGENXBIO COM 75901B107 2,762,116 180,853 7.01 55,215 13.12 0.0029
2023-05-15 2023-03-31 13F REGENXBIO COM 75901B107 2,581,263 -134,926 -4.97 48,812 -20.77 0.0028
2023-05-15 2022-12-31 13F/A-99 REGENXBIO COM 75901B107 2,716,189 96,085 3.67 61,603 -11.04 0.0036
2023-05-15 2022-12-31 13F REGENXBIO COM 75901B107 2,716,189 96,085 61,603 0.0036
2022-11-15 2022-09-30 13F REGENXBIO COM 75901B107 2,620,104 -181,390 -6.47 69,249 0.08 0.0044
2022-08-15 2022-06-30 13F REGENXBIO COM 75901B107 2,801,494 147,728 5.57 69,197 -21.44 0.0041
2022-05-16 2022-03-31 13F REGENXBIO COM 75901B107 2,653,766 163,513 6.57 88,078 8.16 0.0044
2022-02-14 2021-12-31 13F REGENXBIO COM 75901B107 2,490,253 62,815 2.59 81,431 -19.98 0.0039
2021-11-15 2021-09-30 13F REGENXBIO COM 75901B107 2,427,438 163,557 7.22 101,758 15.70 0.0054
2021-08-16 2021-06-30 13F REGENXBIO COM 75901B107 2,263,881 -31,906 -1.39 87,952 12.31 0.0046
2021-07-09 2021-03-31 13F/A-1 REGENXBIO COM 75901B107 2,295,787 474,131 26.03 78,309 -5.23 0.0045
2021-05-17 2021-03-31 13F REGENXBIO COM 75901B107 2,295,787 474,131 78,309 0.0045
2021-02-16 2020-12-31 13F REGENXBIO COM 75901B107 1,821,656 -322,241 -15.03 82,630 40.05 0.0051
2020-11-10 2020-09-30 13F REGENXBIO COM 75901B107 2,143,897 -101,743 -4.53 59,000 -28.66 0.0040
2020-08-14 2020-06-30 13F REGENXBIO COM 75901B107 2,245,640 279,077 14.19 82,707 29.89 0.0060
2020-06-19 2020-03-31 13F/A-1 REGENXBIO COM 75901B107 1,966,563 89,433 4.76 63,677 -17.20 0.0056
2020-05-11 2020-03-31 13F REGENXBIO COM 75901B107 1,966,563 89,433 63,677 5,592.1228
2020-02-06 2019-12-31 13F REGENXBIO COM 75901B107 1,877,130 -221,378 -10.55 76,906 2.94 0.0053
2019-11-14 2019-09-30 13F REGENXBIO COM 75901B107 2,098,508 43,156 2.10 74,707 -29.24 0.0056
2019-08-14 2019-06-30 13F REGENXBIO COM 75901B107 2,055,352 381,565 22.80 105,583 10.07 0.0079
2019-05-15 2019-03-31 13F REGENXBIO COM 75901B107 1,673,787 -300,972 -15.24 95,925 15.79 0.0075
2019-02-12 2018-12-31 13F REGENXBIO COM 75901B107 1,974,759 279,583 16.49 82,841 -35.27 0.0075
2018-11-09 2018-09-30 13F REGENXBIO Common equity shares 75901B107 1,695,176 360,952 27.05 127,989 33.69 0.0098
2018-08-14 2018-06-30 13F REGENXBIO Common equity shares 75901B107 1,334,224 128,875 10.69 95,734 166.04 0.0080
2018-05-15 2018-03-31 13F REGENXBIO Common equity shares 75901B107 1,205,349 131,077 12.20 35,985 0.75 0.0031
2018-02-14 2017-12-31 13F REGENXBIO Common equity shares 75901B107 1,074,272 279,273 35.13 35,718 36.36 0.0029
2017-11-14 2017-09-30 13F REGENXBIO Common equity shares 75901B107 794,999 -85,845 -9.75 26,194 50.55 0.0023
2017-08-14 2017-06-30 13F REGENXBIO Common equity shares 75901B107 880,844 564,129 178.12 17,399 184.58 0.0015
2017-05-15 2017-03-31 13F REGENXBIO Common equity shares 75901B107 316,715 8,895 2.89 6,114 7.06 0.0005
2017-02-09 2016-12-31 13F REGENXBIO Common equity shares 75901B107 307,820 36,336 13.38 5,711 50.13 0.0005
2017-01-13 2016-09-30 13F/A-1 REGENXBIO Common equity shares 75901B107 271,484 33,088 13.88 3,804 99.27 0.0004
2016-11-14 2016-09-30 13F REGENXBIO Common equity shares 75901B107 271,484 3,804
2016-08-12 2016-06-30 13F REGENXBIO Common equity shares 75901B107 238,396 150,371 170.83 1,909 100.95 0.0002
2016-05-20 2016-03-31 13F/A-1 REGENXBIO Common equity shares 75901B107 88,025 30,500 53.02 950 -0.42 0.0001
2016-05-12 2016-03-31 13F REGENXBIO Common equity shares 75901B107 88,025 950
2016-02-16 2015-12-31 13F REGENXBIO Common equity shares 75901B107 57,525 57,525 954 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.